Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cyclopropanation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Suzuki coupling process for Alzheimer's API intermediate. Higher yield, no chromatography, cost-effective manufacturing for global supply chains.
Novel diazomethane catalytic route offers high yield and purity for cyclopropylamine compounds. Reduces waste and cost for scalable pharmaceutical intermediate manufacturing.
Patent CN114591217A reveals a novel lactone-based route for 6,6-dimethyl-3-azabicyclo[3.1.0]hexane, offering superior atom economy and cost reduction in API manufacturing for antiviral drugs.
Novel copper-catalyzed synthesis offers high yields and mild conditions for pharmaceutical intermediates, ensuring supply chain stability and cost efficiency.
Patent CN105384608A details a novel route for isopropyl-phenol derivatives. This report analyzes cost reduction in API manufacturing and supply chain reliability for high-purity intermediates.
Patent CN101735300A details a high-yield route for Drospirenone intermediates. Discover cost-effective steroid synthesis and scalable supply chain solutions.
Patent CN103450072A reveals a novel Simmons-Smith route for R-proline derivatives. Achieve high enantioselectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113651666A details a safe, continuous fixed-bed method for cyclopropanation, offering significant cost reduction and supply chain reliability for energy materials.
This patent details a low-cost drospirenone synthesis avoiding heavy metals. It offers high purity and scalability for reliable pharmaceutical supply chains.
Novel Ir-catalyzed visible light method for polysubstituted cyclopropanes. Enhances yield, reduces by-products, ensures scalable API intermediate production.
Novel synthesis of Solanoeclepin A intermediate SA-01 via asymmetric cyclopropanation. High yield, scalable route for potato cyst nematode control agents.
Novel sulfur ylide method for Formula 1 improves safety and yield for Paxlovid manufacturing, offering a robust alternative to hazardous phosphorus routes.
Patent CN115784968A reveals a safer sulfur ylide route for Formula 1, offering high yields and scalable manufacturing for reliable pharmaceutical intermediate suppliers.
Patent CN1852887A details a novel asymmetric copper complex for high-selectivity cyclopropanation, offering cost reduction in pyrethroid manufacturing and reliable supply chain solutions.
Patent CN110467527A reveals ruthenium-catalyzed route for high-purity agrochemical intermediate with significant cost and supply chain advantages.
Advanced patent CN115322136B enables cost-effective production of Paxlovid intermediates. Discover scalable routes for high-purity pharmaceutical intermediates supply.
Novel preparation method for Compound I (CAS 565456-77-1) via efficient cyclopropanation. Reduces toxicity and steps for API manufacturing supply chains.
Novel 7-step route avoids resolution, offering cost-effective manufacturing of chiral proline derivatives for pharmaceutical intermediates.
Patent CN105949153B reveals a novel 4-step synthesis for Tasimelteon. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediate procurement.
Patent CN1020451C details a novel enantioselective route for cis/trans hemicaronic aldehyde derivatives, offering superior stereocontrol for pyrethroid manufacturing.